☆ 4.6 Article

D4Z4 Methylation Levels Combined with a Machine Learning Pipeline Highlight Single CpG Sites as Discriminating Biomarkers for FSHD Patients

CELLS (2022)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Methylation of the 4q35 D4Z4 repeat defines disease status in facioscapulohumeral muscular dystrophy

Hannes Erdmann et al.

Summary: Researchers developed and validated a multistage diagnostic workflow, FSHD-MPA, which combines high-throughput methylation analysis with genetic parameters, to accurately determine the epigenetic parameters of FSHD and distinguish between FSHD1 and FSHD2.

BRAIN (2023)

Add to Collection

Article Neurosciences

Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis

Sai Zhang et al.

Summary: This study developed a machine learning approach called RefMap that successfully identified 690 ALS-associated genes by integrating functional genomics with GWAS summary statistics, resulting in a 5-fold increase in recovered heritability. The study also discovered KANK1 as a new ALS gene and confirmed its role through experiments on human neurons.

NEURON (2022)

Add to Collection

Article Clinical Neurology

Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning

Mauro Monforte et al.

Summary: MRI patterns have been identified to have high diagnostic accuracy in distinguishing FSHD from other muscle disorders, with the combination of trapezius involvement and bilateral subscapularis muscle sparing showing the best diagnostic accuracy. This pattern can correctly identify 91% of atypical FSHD patients and certain combinations of muscle involvement can be pathognomonic for FSHD.

JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Simultaneous measurement of the size and methylation of chromosome 4qA-D4Z4 repeats in facioscapulohumeral muscular dystrophy by long-read sequencing

Yosuke Hiramuki et al.

Summary: In this study, the researchers developed a new method for the diagnosis of Facioscapulohumeral muscular dystrophy (FSHD) using Nanopore long-read sequencing. They also found a correlation between methylation status and patient phenotypes, providing insights into the disease pathogenesis.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Health Care Sciences & Services

WARE: Wet AMD Risk-Evaluation Tool as a Clinical Decision-Support System Integrating Genetic and Non-Genetic Factors

Carlo Fabrizio et al.

Summary: In this article, an open-source computational tool named WARE is introduced for assessing the individual risk profile of wet AMD. The tool utilizes genetic and non-genetic factors to evaluate the risk and provides a user-friendly interface for clinicians to report risk assessment results. It can be used to compute disease risk adjusted to different populations and to promote preventive actions and personalized medicine.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Review Cell Biology

Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD

Valerio Caputo et al.

Summary: Despite knowledge of the main mechanisms of FSHD, the complexity and variation of the disease make diagnosis, characterization, and genotype-phenotype correlation difficult. Further research is needed to understand the genetic and epigenetic factors involved in FSHD and develop novel treatment strategies.

CELLS (2022)

Add to Collection

Review Clinical Neurology

Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings

Fangzhi Frank Jia et al.

Summary: Facioscapulohumeral muscular dystrophy type 2 (FSHD2) is a rare genetic disease that shows virtually no difference from FSHD1, both of which are caused by epigenetic derepression of the transcription factor DUX4 in skeletal muscle cells. FSHD2 is a digenic disease, with mutations in genes SMCHD1, DNMT3B, and LRIF1 being identified as causes. Clinicians need to stay updated on recent developments in understanding FSHD2 due to its complexity.

NEUROMUSCULAR DISORDERS (2021)

Add to Collection

Article Biology

Deep learning segmentation of transverse musculoskeletal ultrasound images for neuromuscular disease assessment

Francesco Marzola et al.

Summary: The study introduced a deep learning algorithm for cross-sectional area segmentation in musculoskeletal ultrasound images, providing quantitative grayscale analysis useful for muscle studies and validated the results in a large dataset. The algorithm demonstrated slightly lower performance in abnormal muscles compared to manual segmentation, but maintained good discrimination between healthy and abnormal muscle images.

COMPUTERS IN BIOLOGY AND MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Precise Epigenetic Analysis Using Targeted Bisulfite Genomic Sequencing Distinguishes FSHD1, FSHD2, and Healthy Subjects

Taylor Gould et al.

Summary: The true prevalence of facioscapulohumeral muscular dystrophy (FSHD) remains unknown, but epigenetic analysis could provide a diagnostic pathway for sequence-based diagnosis. Conflicting results from studies assessing DNA methylation at the FSHD locus have made the utility of this technique controversial for FSHD diagnosis.

DIAGNOSTICS (2021)

Add to Collection

Article Health Care Sciences & Services

Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders

Stefania Zampatti et al.

Summary: The management of neuropsychiatric disorders involves various pharmacological treatments. By using the NeuroPGx software to predict drug-drug interactions based on CYP gene metabolism, dosage adjustments can be made effectively. Combining the software with OpenArray technology results in an easy, quick, and highly automated device for routine clinical practice.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Review Genetics & Heredity

Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy

Anna Greco et al.

CLINICAL GENETICS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies

Ana Nikolic et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Clinical Neurology

Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy

Kohei Hamanaka et al.

NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging

G. Giacomucci et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis

Giulia Ricci et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Medicine, General & Internal

Artificial Intelligence in Medicine: Today and Tomorrow

Giovanni Briganti et al.

FRONTIERS IN MEDICINE (2020)

Add to Collection

Review Genetics & Heredity

Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era

Stefania Zampatti et al.

NEUROGENETICS (2019)

Add to Collection

Article Genetics & Heredity

The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy

Charis L. Himeda et al.

Annual Review of Genomics and Human Genetics (2019)

Add to Collection

Article Clinical Neurology

FSHD1 and FSHD2 form a disease continuum

Sabrina Sacconi et al.

NEUROLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

The variability of SMCHD1 gene in FSHD patients: evidence of new mutations

Claudia Strafella et al.

HUMAN MOLECULAR GENETICS (2019)

Add to Collection

Article Genetics & Heredity

Methylation hotspots evidenced by deep sequencing in patients with facioscapulohumeral dystrophy and mosaicism

Stephane Roche et al.

NEUROLOGY-GENETICS (2019)

Add to Collection

Review Medicine, General & Internal

Next-Generation Sequencing to Diagnose Suspected Genetic Disorders

David R. Adams et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Clinical Neurology

Digenic Inheritance of Shortened Repeat Units of the D4Z4 Region and a Loss-of-Function Variant in SMCHD1 in a Family With FSHD

Raffaella Cascella et al.

FRONTIERS IN NEUROLOGY (2018)

Add to Collection

Article Genetics & Heredity

Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy

Marlinde L. van den Boogaard et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2016)

Add to Collection

Article Clinical Neurology

Magnetic Resonance Imaging in a Large Cohort of Facioscapulohumeral Muscular Dystrophy Patients: Pattern Refinement and Implications for Clinical Trials

Giorgio Tasca et al.

ANNALS OF NEUROLOGY (2016)

Add to Collection

Article Genetics & Heredity

Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2

Patrizia Calandra et al.

JOURNAL OF MEDICAL GENETICS (2016)

Add to Collection

Article Oncology

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy

Takako I. Jones et al.

CLINICAL EPIGENETICS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1

Mirjam Larsen et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2

Richard J. L. F. Lemmers et al.

HUMAN MOLECULAR GENETICS (2015)

Add to Collection

Article Clinical Neurology

Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers

Marie-Cecile Gaillard et al.

NEUROLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

DNA Methylation Analysis of the Macrosatellite Repeat Associated with FSHD Muscular Dystrophy at Single Nucleotide Level

Claudia Huichalaf et al.

PLOS ONE (2014)

Add to Collection

Article Oncology

Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing

Takako I. Jones et al.

CLINICAL EPIGENETICS (2014)

Add to Collection

Article Genetics & Heredity

The FSHD2 Gene SMCHD1 Is a Modifier of Disease Severity in Families Affected by FSHD1

Sabrina Sacconi et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2013)

Add to Collection

Article Clinical Neurology

A focal domain of extreme demethylation within D4Z4 in FSHD2

Lynn M. Hartweck et al.

NEUROLOGY (2013)

Add to Collection

Article Genetics & Heredity

Large-Scale Population Analysis Challenges the Current Criteria for the Molecular Diagnosis of Fascioscapulohumeral Muscular Dystrophy

Isabella Scionti et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2012)

Add to Collection

Article Genetics & Heredity

Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity

Sabrina Sacconi et al.

JOURNAL OF MEDICAL GENETICS (2012)

Add to Collection

Article Genetics & Heredity

Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy

PGM van Overveld et al.

NATURE GENETICS (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.